US IPO hopefuls forge ahead with listing plans amid market swings

A slew of companies ​across sectors, from biotech to ​real estate investment trust, launched IPO roadshows on Monday, ​as issuers prepare to go ahead with their listing plans amid the Middle East conflict.Analysts say the stage is set for a gradual pickup in activity in the ‌coming months ⁠if volatility ⁠subsides.Convenience store owner Yesway, proteomics company Alamar Biosciences, obesity drug developer Kailera Therapeutics ​and REIT National Healthcare Properties unveiled the terms for their...

Original Source

Read the full article at Economictimes →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.